Skip to main content
Skip to main content
PACS logo

PACS Group, Inc. (PACS) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$44.85 +$0.25 (+0.56%) |Exceptional · 90
PACS Group, Inc. (PACS) bottom line: Bullish Lean — our Council read (69/100) and AI Score (90/100) broadly agree. Strongest signal: Ray Dalio bullish · Biggest watch-out: Izzy Englander bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $7.10B| P/E Ratio: 26.38| Vol: 900.0K| Target: $56.67 (+26.4%) (Sep 5, 2026) (estimate, not advice)| 52-wk range: $8.00 – $49.49

P/E 26.38 means the share price is 26.38 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $7.10B is the value of all shares combined. Beta 0.06: the stock has moved about 94% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

PACS Group, Inc. (PACS) trades at $44.85 with MoonshotScore 90/100 (Grade A+). PACS Group, Inc. operates post-acute healthcare facilities, providing senior care, assisted living, and independent living options. Market cap: $7.10B, Sector: Financial services.

Price as of Sep 10, 2026 · Last analyzed: May 10, 2026
PACS Group, Inc. operates post-acute healthcare facilities, providing senior care, assisted living, and independent living options. The company focuses on delivering comprehensive healthcare services within its communities.

PACS stock analysis for 2026: Analysts have set a consensus price target of $56.67 for PACS Group, Inc., suggesting 26.4% upside from the current price of $44.85. The AI MoonshotScore is 90/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the PACS film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 69/100 · B+

PACS: 1/3 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 90/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Weak Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Strong Is the market already moving on this?

Strongest side: Growth Durability (10/10, Strong). Weakest side: Financial Safety (4/10, Weak).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

PACS Group, Inc. (PACS) Financial Services Profile

CEOJason Murray
Employees47,455
HeadquartersFarmington, UT, US
IPO Year2024

PACS Group, Inc. is a holding company providing post-acute healthcare facilities and services, including senior care and assisted living. With a market capitalization of $7.10B, PACS operates in the financial services sector, focusing on delivering comprehensive healthcare solutions within its communities and demonstrating a beta of 0.06.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 10, 2026

What Is the Investment Thesis for PACS?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

The company's focus on senior care, assisted living, and independent living options caters to the increasing demand driven by an aging population. With a market capitalization of $7.10B and a profit margin of 3.6%, PACS demonstrates its ability to generate revenue and maintain profitability. Key growth catalysts include expanding its network of facilities and enhancing service offerings. However, potential risks include regulatory changes and competition within the healthcare sector. The company's low beta of 0.06 indicates relatively low volatility compared to the market. Investors should monitor PACS Group's financial performance, expansion plans, and ability to navigate regulatory challenges to assess its long-term growth potential.

Based on FMP financials and quantitative analysis

PACS Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $7.10B reflects PACS Group's significant presence in the post-acute healthcare market.

  • Profit margin of 3.6% indicates the company's ability to generate profits from its operations.
  • Gross margin of 21.9% demonstrates the efficiency of PACS Group's service delivery and cost management.
  • P/E ratio of 26.38 suggests investor confidence in the company's future earnings potential.
  • Beta of 0.06 indicates low volatility compared to the overall market, making it a potentially stable investment.

Who Are PACS's Competitors?

PACS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
SF Stifel Financial Corp. $79.69 -1.19% $12.1B 685-pillar
BIPH Brookfield Infrastructure Finance ULC 5 % Notes 2021-24.05.81 Global $15.60 +0.65% $5.70B 489-signal
VOYA Voya Financial, Inc. $102.67 +0.54% $9.31B 715-pillar
CCXI ChemoCentryx, Inc. $12.81 -2.95% $537M 455-pillar
NWAX NWAX $10.14 +0.03% $505M 495-pillar
BBCQ Bleichroeder Acquisition Corp. II $9.79 -5.68% $375M
TREE LendingTree, Inc. $26.89 +1.24% $375M 545-pillar
SAC SAC $10.11 0.00% $317M 495-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are PACS's Key Strengths?

Established presence in the post-acute healthcare market.

  • Comprehensive range of senior care services.
  • Experienced management team.
  • Strong network of healthcare facilities.

What Are PACS's Weaknesses?

Reliance on government funding and reimbursement rates.

  • Exposure to regulatory changes in the healthcare industry.
  • Competition from other healthcare providers.
  • Potential for operational challenges in managing healthcare facilities.

What Could Drive PACS Stock Higher?

Expansion into new geographic markets to diversify revenue streams.

  • Continued acquisition of post-acute care facilities to increase market share.
  • Implementation of technology solutions to improve care delivery and efficiency.

What Are the Key Risks for PACS?

Rich valuation — a P/E of 26.38 runs well above the Financial Services sector’s ~17.50x, leaving little room for a miss.

  • Insider selling — insiders were net sellers of roughly $26.2M recently.
  • Changes in government regulations and reimbursement policies affecting revenue.
  • Increased competition from other healthcare providers.
  • Economic downturn affecting demand for senior care services.
  • Liability claims and lawsuits.

What Are the Growth Opportunities for PACS?

  • Expanding Service Offerings: PACS Group can grow by expanding its service offerings to include specialized care programs, such as memory care and rehabilitation services. The market for specialized care is growing, with an estimated market size of $80 billion. By offering a wider range of services, PACS can attract more residents and increase revenue per facility. Timeline: Within the next 2-3 years, PACS can implement these programs across its existing facilities.
  • Acquiring New Facilities: PACS Group can pursue growth through strategic acquisitions of existing post-acute care facilities. The market for acquisitions is active, with numerous opportunities to acquire underperforming facilities and improve their operations. The company can leverage its expertise in managing healthcare facilities to turn around acquired facilities and increase profitability. Timeline: Ongoing, with potential acquisitions evaluated on a quarterly basis.
  • Geographic Expansion: PACS Group can expand its geographic footprint by entering new markets with a high demand for senior care services. The company can target regions with a growing senior population and limited availability of post-acute care facilities. By expanding into new markets, PACS can diversify its revenue streams and reduce its reliance on existing markets. Timeline: Within the next 3-5 years, PACS can identify and enter new geographic markets.
  • Technology Integration: PACS Group can invest in technology to improve care delivery and operational efficiency. The company can implement electronic health records (EHRs), telehealth solutions, and remote monitoring devices to enhance the quality of care and reduce costs. The market for healthcare technology is growing rapidly, with an estimated market size of $280 billion. Timeline: Ongoing, with continuous investment in new technologies.
  • Partnerships and Collaborations: PACS Group can form partnerships and collaborations with other healthcare providers, such as hospitals and physician groups, to create integrated care networks. By partnering with other providers, PACS can improve care coordination and access to services for its residents. The market for integrated care is growing, with an increasing emphasis on value-based care models. Timeline: Within the next 1-2 years, PACS can establish strategic partnerships with key healthcare providers.

What Are PACS's Competitive Advantages?

  • Established network of healthcare facilities.
  • Expertise in managing post-acute care services.
  • Focus on providing comprehensive care.
  • Strong relationships with healthcare professionals.

What Does PACS Do?

PACS Group, Inc., established in 2013 by Jason Murray and Mark Hancock, is a holding company specializing in post-acute healthcare facilities, professionals, and ancillary services. Headquartered in Farmington, UT, the company offers a range of senior care options, including assisted living and independent living, within its communities. PACS Group aims to provide comprehensive healthcare services tailored to the needs of its residents. The company's business model focuses on acquiring and managing healthcare facilities, employing healthcare professionals, and delivering ancillary services to support its operations. With 32,433 employees, PACS Group has grown to become a significant player in the post-acute care sector. The company's financial performance reflects its operational scale, with a market capitalization of $7.10B. PACS Group's commitment to providing quality care and comprehensive services positions it as a key provider in the senior care market. The company's growth strategy involves expanding its network of facilities and enhancing its service offerings to meet the evolving needs of the aging population. PACS Group's focus on post-acute care addresses a critical segment of the healthcare industry, providing essential services to seniors and individuals requiring specialized care.

What Products and Services Does PACS Offer?

  • Operates post-acute healthcare facilities.
  • Provides senior care services.
  • Offers assisted living options.
  • Provides independent living options.
  • Manages healthcare professionals.
  • Delivers ancillary services.

How Does PACS Make Money?

  • Generates revenue through fees for senior care, assisted living, and independent living services.
  • Manages and operates healthcare facilities.
  • Employs healthcare professionals to provide care.
  • Provides ancillary services to support its operations.

What Industry Does PACS Operate In?

PACS Group, Inc. operates within the financial conglomerates industry, which intersects with the healthcare sector through its provision of post-acute care services. The industry is characterized by increasing demand for senior care and assisted living facilities, driven by the aging population. The competitive landscape includes other healthcare providers and financial institutions involved in managing healthcare facilities. PACS Group's focus on post-acute care positions it to capitalize on the growing need for specialized healthcare services for seniors. Market trends include the integration of technology to improve care delivery and the increasing emphasis on value-based healthcare models.

Who Are PACS's Key Customers?

  • Seniors requiring post-acute care.
  • Individuals seeking assisted living options.
  • Individuals seeking independent living options.
  • Families seeking care for their loved ones.
Model self-rating on this text: 68% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 38 days ago
  • Covered by analysts

Why 90?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.54 Financial-health checklist (Financial Strength)
  • +0.52 Return on equity (Business Quality)
  • +0.36 12-month price trend (Momentum)

What is holding it back

  • -0.60 Net debt vs earnings (Financial Strength)
  • -0.60 Debt to equity (Financial Strength)
  • -0.15 Short-term liquidity (Financial Strength)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 90
2026-08-26 90
2026-08-29 92
2026-09-01 89
2026-09-04 89
2026-09-07 89
2026-09-10 90

What changed?

The score has stayed at 90.

What moved it up or down:

  • -13 Valuation
  • +7 Momentum
  • -6 Financial Strength

Over the same 18 days the stock moved +0.8%.

PACS Group, Inc. (PACS) Valuation Context

Valued at $7.10B, PACS is classified as a mid-cap stock. Analyst price targets span from $48.00 to $62.00, with a consensus of $56.67. At the current price of $44.85, that implies approximately 26% upside potential. Relative to its peer group, PACS's quantitative score of 90/100 is above the peer average of 55/100.

PACS Revenue & Earnings Trend

In Q2 FY2026, PACS generated $1.43B in top-line revenue, marking a sequential increase of 0.5%. The company recorded net income of $76.4M, with diluted EPS of $0.47. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Financial Services company. Across the four most recent quarters, PACS averaged $0.42 in diluted EPS.

Company Profile

PACS Group, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Salt Lake City, US. The company is led by CEO Jason Murray. PACS has traded publicly since 2024.

ROE 27%

Key Financial Metrics

Return on equity for PACS Group, Inc. stands at 27.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.8%, showing how much profit it generates from its asset base. PACS trades at a trailing price-to-earnings ratio of 26.38, above the Financial Services sector average of ~17.50x. Its free cash flow yield is 6.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.91 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 4.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9

Financial Health

PACS Group, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.25 places it in the grey zone, a middle ground that warrants monitoring.

4/8 beats

Earnings Track Record

PACS Group, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 5.3% above estimates on average.

Net selling

Insider Activity

Over the past six months, PACS Group, Inc. insiders filed 30 SEC Form 4 transactions — 29 sales and 1 purchases. On net that is roughly 676K shares disposed (about $26.2M), a signal worth weighing alongside the fundamentals.

PACS Financials

Fundamental Snapshot

Revenue Growth (FY)
+29.3%
Net Income Growth (FY)
+243.5%
EPS Growth (FY)
+223.7%
P/E (TTM)
26.38
Return on Equity (TTM)
+27.2%
Current Ratio
0.9
EV/EBITDA (TTM)
20.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Established presence in the post-acute healthcare market.
  • Comprehensive range of senior care services.
  • Experienced management team.
  • Strong network of healthcare facilities.

Bear Case

  • Reliance on government funding and reimbursement rates.
  • Exposure to regulatory changes in the healthcare industry.
  • Competition from other healthcare providers.
  • Potential for operational challenges in managing healthcare facilities.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $1.43B $76M $0.47
Q1 FY2026 $1.42B $81M $0.50
Q4 FY2025 $1.36B $60M $0.38
Q3 FY2025 $1.34B $52M $0.32

Q2 FY2026 · filed 4 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

PACS Latest News

PACS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PACS.

Price Targets

Low
$48.00
Consensus
$56.67
High
$62.00

Median: $60.00 (+26.4% from current price)

Source: FMP analyst consensus · as of Sep 5, 2026 · an estimate, not advice

PACS MoonshotScore

90/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. PACS scores 90/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Jason Murray

CEO

Jason Murray is the co-founder and CEO of PACS Group, Inc. He has extensive experience in the healthcare industry, with a focus on post-acute care services. Prior to founding PACS Group, Murray held leadership positions in various healthcare organizations, where he gained expertise in managing healthcare facilities and delivering quality care. His background includes a strong understanding of the regulatory environment and the financial aspects of the healthcare industry. Murray's leadership has been instrumental in the growth and success of PACS Group.

Track Record: Under Jason Murray's leadership, PACS Group has grown from a startup to a significant player in the post-acute healthcare market. He has overseen the expansion of the company's network of facilities and the enhancement of its service offerings. Murray has also been instrumental in building a strong management team and fostering a culture of quality and innovation. His strategic decisions have positioned PACS Group for continued growth and success.

What Investors Ask About PACS Group, Inc. (PACS) — Financial Services

What does the AI Score mean for PACS?

PACS holds an AI Score of 90/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. PACS Group, Inc. operates post-acute healthcare facilities, providing senior care, assisted living, and independent living options.

Is PACS a good stock?

Stock Expert AI does not rate PACS buy, sell or hold. PACS Group, Inc. carries a MoonshotScore of 90/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about PACS stock?

Analyst coverage of PACS Group, Inc. is still emerging, with limited consensus available. Key valuation metrics include a P/E ratio of 26.38, reflecting investor expectations for future earnings growth.

What are the main risks for PACS?

PACS Group, Inc. faces several risks, including changes in government regulations and reimbursement policies, which could affect its revenue. Increased competition from other healthcare providers could also put pressure on its market share.

What are the key factors to evaluate for PACS?

PACS Group, Inc. (PACS) holds an AI score of 90/100 (high). P/E: 26.38x vs the S&P 500's ~20-25x. Analysts target $56.67 (+26%). Not financial advice.

How frequently does PACS data refresh on this page?

PACS's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven PACS's recent stock price performance?

PACS Group, Inc. (PACS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in the post-acute healthcare market. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider PACS overvalued or undervalued right now?

PACS Group, Inc. (PACS) trades at 26.38x earnings. Analysts target $56.67 (+26%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of PACS?

Yes, most major brokerages offer fractional shares of PACS Group, Inc. (PACS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are as of the latest available reporting period.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover